Ateliosis: Difference between revisions
CSV import |
CSV import |
||
| Line 46: | Line 46: | ||
{{medicine-stub}} | {{medicine-stub}} | ||
{{No image}} | {{No image}} | ||
__NOINDEX__ | |||
Latest revision as of 05:12, 17 March 2025
Ateliosis is a medical condition characterized by a form of dwarfism associated with the deficiency of growth hormone. This condition results in the affected individual having a short stature and delayed physical development, while maintaining normal body proportions.
Etiology[edit]
Ateliosis is primarily caused by a deficiency in the secretion of growth hormone from the pituitary gland. This deficiency can be due to congenital factors, genetic mutations, or acquired conditions that affect the pituitary gland's function.
Clinical Features[edit]
Individuals with ateliosis typically present with:
- Short stature
- Delayed skeletal maturation
- Delayed puberty
- Normal body proportions
Unlike other forms of dwarfism, such as achondroplasia, ateliosis does not involve disproportionate limb growth.
Diagnosis[edit]
The diagnosis of ateliosis involves a combination of clinical evaluation and diagnostic tests, including:
- Measurement of growth hormone levels
- X-rays to assess bone age
- MRI of the pituitary gland
- Genetic testing to identify potential mutations
Treatment[edit]
Treatment for ateliosis often involves hormone replacement therapy. The primary treatment is the administration of synthetic growth hormone to stimulate growth and development. Early diagnosis and treatment are crucial for achieving optimal outcomes.
Prognosis[edit]
The prognosis for individuals with ateliosis varies depending on the severity of the growth hormone deficiency and the timing of treatment initiation. With appropriate treatment, many individuals can achieve near-normal height and development.
See Also[edit]
References[edit]
External Links[edit]